Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AstraZeneca
Pharmaceuticals
GSK
Novartis
Johnson and Johnson
Sanofi
Pfizer
Topics

Advertisement

Advertisement

AstraZeneca

Share

Top Latest Popular

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval Proactive Investors (US) 17h

Proactive Investors (US) 17h

AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah Zacks 18h

Zacks 18h

AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 1d

ShareCast 1d

Advertisement

Etcamah® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer Business Wire (Press Release) 3d

Business Wire (Press Release) 3d

Advertisement

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer Hospital Management 1d

Hospital Management 1d

What does AstraZeneca (LSE:AZN) news mean for its cancer and pipeline growth? Simply Wall St 6d

Simply Wall St 6d

Advertisement

Advertisement

Latest

Yesterday

Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval Proactive Investors (US) 15:05 Mon, 07 Sep

AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah Zacks 14:51 Mon, 07 Sep

FDA overrides adcomm and approves AZ's oral SERD pharmaphorum 11:25 Mon, 07 Sep

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer Hospital Management 10:18 Mon, 07 Sep

AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 09:04 Mon, 07 Sep

AstraZeneca's breast cancer drug gets accelerated US approval, Spire Healthcare agrees to £1.03bn takeover bid ShareCast 07:53 Mon, 07 Sep

Saturday

Etcamah® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer Business Wire (Press Release) 00:04 Sat, 05 Sep

Friday

Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s Etcamah™ (camizestrant) in Advanced Breast Cancer Business Wire (Press Release) 23:14 Fri, 04 Sep

AstraZeneca’s Etcamah Gets Long-Awaited FDA Breast Cancer Approval Scrip Pharma Intelligence 22:58 Fri, 04 Sep

AstraZeneca’s Breast Cancer Pill Gets Approval From the FDA Bloomberg Law 22:27 Fri, 04 Sep

Advertisement

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis